The Effects of Botulinum Toxin on Oral Aperture in Patients With Scleroderma
Clinical trial NCT04523506 · COMPLETED
Trial details
- NCT number
- NCT04523506
- Sponsor
- University of Texas Southwestern Medical Center
- Status
- COMPLETED
- Phase
- Early Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2020-05-08
- Primary completion
- 2021-04-22
- Enrollment
- 17
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.